These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20438534)

  • 1. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
    Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
    Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
    Moriarty P; Sosland R; Gibson C; Belmont J
    Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein adsorption during LDL-apheresis: proteomic analysis.
    Dihazi H; Koziolek MJ; Söllner T; Kahler E; Klingel R; Neuhoff R; Strutz F; Mueller GA
    Nephrol Dial Transplant; 2008 Sep; 23(9):2925-35. PubMed ID: 18398017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
    Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
    Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
    Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
    Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
    J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
    Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
    Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U; Arneth B; Siegert G; Siegels D; Fischer S; Julius U; Bornstein SR
    Atheroscler Suppl; 2013 Jan; 14(1):115-22. PubMed ID: 23357152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
    Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
    Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
    Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
    Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan.
    Bosch T; Wendler T
    Ther Apher Dial; 2004 Aug; 8(4):269-74. PubMed ID: 15274676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.
    Gülle S; Bak M; Serdaroglu E; Can D; Karabay O
    Ther Apher Dial; 2010 Feb; 14(1):87-92. PubMed ID: 20438523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.